Universal definition of myocardial infarction

Kristian Thygesen; Joseph S. Alpert; Harvey D. White

doi:10.1093/eurheartj/ehm355

Universal definition of myocardial infarction

Kristian Thygesen, Joseph S. Alpert, Harvey D. White

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	2525-2538
Number of pages	14
Journal	European Heart Journal
Volume	28
Issue number	20
DOIs	https://doi.org/10.1093/eurheartj/ehm355
State	Published - Oct 2007

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1093/eurheartj/ehm355

Cite this

@article{2355be41e6784cd0b344f0f70dc4d56b,

title = "Universal definition of myocardial infarction",

author = "Kristian Thygesen and Alpert, {Joseph S.} and White, {Harvey D.}",

note = "Funding Information: We are indebted to Professor Erling Falk MD for reviewing the section on {\textquoteleft}Pathology.{\textquoteright} Furthermore, we are very grateful to the dedicated staff of the Guidelines Department of the ESC. We would also like to thank and to acknowledge the contribution of the following companies through unrestricted educational grants, none of whom were involved in the development of this publication and in no way influenced its contents. Premium observer: GlaxoSmithKline. Observer: AstraZeneca, Beckman-Coulter, Dade Behring, Roche Diagnostics, Sanofi-Aventis, Servier. ",

year = "2007",

month = oct,

doi = "10.1093/eurheartj/ehm355",

language = "English (US)",

volume = "28",

pages = "2525--2538",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "20",

}

TY - JOUR

T1 - Universal definition of myocardial infarction

AU - Thygesen, Kristian

AU - Alpert, Joseph S.

AU - White, Harvey D.

N1 - Funding Information: We are indebted to Professor Erling Falk MD for reviewing the section on ‘Pathology.’ Furthermore, we are very grateful to the dedicated staff of the Guidelines Department of the ESC. We would also like to thank and to acknowledge the contribution of the following companies through unrestricted educational grants, none of whom were involved in the development of this publication and in no way influenced its contents. Premium observer: GlaxoSmithKline. Observer: AstraZeneca, Beckman-Coulter, Dade Behring, Roche Diagnostics, Sanofi-Aventis, Servier.

PY - 2007/10

Y1 - 2007/10

UR - http://www.scopus.com/inward/record.url?scp=35448971466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35448971466&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehm355

DO - 10.1093/eurheartj/ehm355

M3 - Article

C2 - 17951287

AN - SCOPUS:35448971466

VL - 28

SP - 2525

EP - 2538

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 20

ER -

Universal definition of myocardial infarction

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this